• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $OCS

    Oculis Holding AG

    Subscribe to $OCS
    $OCS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    IPO Year:

    Exchange: NASDAQ

    Recent Analyst Ratings for Oculis Holding AG

    DatePrice TargetRatingAnalyst
    12/5/2023$30.00Buy
    Chardan Capital Markets
    10/5/2023$35.00Buy
    Stifel
    6/14/2023$22.00Buy
    BofA Securities
    6/12/2023$28.00Buy
    H.C. Wainwright
    6/8/2023$58.00Outperform
    Robert W. Baird
    5/10/2023$23.00Buy
    Pareto
    4/28/2023$27.00Outperform
    Wedbush
    See more ratings

    Oculis Holding AG SEC Filings

    See more
    • SEC Form S-8 filed by Oculis Holding AG

      S-8 - Oculis Holding AG (0001953530) (Filer)

      6/5/25 4:38:25 PM ET
      $OCS
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 6-K filed by Oculis Holding AG

      6-K - Oculis Holding AG (0001953530) (Filer)

      6/5/25 4:05:17 PM ET
      $OCS
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 6-K filed by Oculis Holding AG

      6-K - Oculis Holding AG (0001953530) (Filer)

      5/9/25 4:10:10 PM ET
      $OCS
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 6-K filed by Oculis Holding AG

      6-K - Oculis Holding AG (0001953530) (Filer)

      5/8/25 4:15:13 PM ET
      $OCS
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 6-K filed by Oculis Holding AG

      6-K - Oculis Holding AG (0001953530) (Filer)

      4/15/25 4:05:24 PM ET
      $OCS
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 20-F filed by Oculis Holding AG

      20-F - Oculis Holding AG (0001953530) (Filer)

      3/11/25 4:35:27 PM ET
      $OCS
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 6-K filed by Oculis Holding AG

      6-K - Oculis Holding AG (0001953530) (Filer)

      3/11/25 4:30:05 PM ET
      $OCS
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 6-K filed by Oculis Holding AG

      6-K - Oculis Holding AG (0001953530) (Filer)

      2/14/25 4:28:47 PM ET
      $OCS
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 424B5 filed by Oculis Holding AG

      424B5 - Oculis Holding AG (0001953530) (Filer)

      2/14/25 4:03:00 PM ET
      $OCS
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Amendment: SEC Form SCHEDULE 13G/A filed by Oculis Holding AG

      SCHEDULE 13G/A - Oculis Holding AG (0001953530) (Subject)

      2/12/25 4:30:03 PM ET
      $OCS
      Biotechnology: Pharmaceutical Preparations
      Health Care

    Oculis Holding AG Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Chardan Capital Markets initiated coverage on Oculis Holding AG with a new price target

      Chardan Capital Markets initiated coverage of Oculis Holding AG with a rating of Buy and set a new price target of $30.00

      12/5/23 8:03:01 AM ET
      $OCS
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Stifel initiated coverage on Oculis Holding AG with a new price target

      Stifel initiated coverage of Oculis Holding AG with a rating of Buy and set a new price target of $35.00

      10/5/23 7:50:21 AM ET
      $OCS
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • BofA Securities initiated coverage on Oculis Holding AG with a new price target

      BofA Securities initiated coverage of Oculis Holding AG with a rating of Buy and set a new price target of $22.00

      6/14/23 8:10:40 AM ET
      $OCS
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • H.C. Wainwright initiated coverage on Oculis Holding AG with a new price target

      H.C. Wainwright initiated coverage of Oculis Holding AG with a rating of Buy and set a new price target of $28.00

      6/12/23 8:32:05 AM ET
      $OCS
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Robert W. Baird initiated coverage on Oculis Holding AG with a new price target

      Robert W. Baird initiated coverage of Oculis Holding AG with a rating of Outperform and set a new price target of $58.00

      6/8/23 7:43:11 AM ET
      $OCS
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Pareto initiated coverage on Oculis Holding AG with a new price target

      Pareto initiated coverage of Oculis Holding AG with a rating of Buy and set a new price target of $23.00

      5/10/23 6:27:47 AM ET
      $OCS
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Wedbush initiated coverage on Oculis Holding AG with a new price target

      Wedbush initiated coverage of Oculis Holding AG with a rating of Outperform and set a new price target of $27.00

      4/28/23 7:22:50 AM ET
      $OCS
      Biotechnology: Pharmaceutical Preparations
      Health Care